31 related articles for article (PubMed ID: 9877238)
1. Advances in supportive therapy.
Facchini T
Zentralbl Gynakol; 1996; 118(10):589-90. PubMed ID: 8912478
[No Abstract] [Full Text] [Related]
2. [Hypomagnesemia in patients of gynecologic neoplasms following chemotherapy with cisplatin].
Li L; Huang W; Zhu B
Zhonghua Fu Chan Ke Za Zhi; 1995 Jun; 30(6):363-5. PubMed ID: 7555373
[TBL] [Abstract][Full Text] [Related]
3. Influence on erythropoietin levels of treatment with cisplatinum-endoxan.
Lechner W; Artner-Dworzak E; Sölder E; Sachsenmaier M; Kölle D; Moncayo H; Reitsamer R
Arch Gynecol Obstet; 1992; 252(1):49-53. PubMed ID: 1417088
[TBL] [Abstract][Full Text] [Related]
4. Domiciliary chemotherapy for malignant disease.
Malone J; Kavanagh J; Crosson K; Streckfuss B
Eur J Gynaecol Oncol; 1986; 7(2):120-1. PubMed ID: 3720782
[TBL] [Abstract][Full Text] [Related]
5. Gynecologic cancer treated with a chemotherapy regimen containing cisplatin.
Wheelock JB
Gynecol Oncol; 1989 Mar; 32(3):401. PubMed ID: 2920965
[No Abstract] [Full Text] [Related]
6. Combining novel agents with radiotherapy for gynecologic malignancies: beyond the era of cisplatin.
Lin LL; Lakomy DS; Ning MS; Simpkins F; Jhingran A
Int J Gynecol Cancer; 2020 Apr; 30(4):409-423. PubMed ID: 32193219
[TBL] [Abstract][Full Text] [Related]
7. Severe neurotoxicity, ototoxicity and nephrotoxicity following high-dose cisplatin and amifostine.
Sastry J; Kellie SJ
Pediatr Hematol Oncol; 2005; 22(5):441-5. PubMed ID: 16020136
[TBL] [Abstract][Full Text] [Related]
8. Phase I study of amifostine as a cytoprotector of the gemcitabine/cisplatin combination in patients with advanced solid malignancies.
Haigentz M; Kim M; Sorich J; Lee J; Hochster H; Macapinlac M; Mirchandani D; Sewak S; Pavlick A; Volm M; Hamilton A; Muggia FM
Anticancer Drugs; 2003 Apr; 14(4):321-6. PubMed ID: 12679737
[TBL] [Abstract][Full Text] [Related]
9. Amifostine in reducing cisplatin toxicity.
Markman M
Semin Oncol; 1998 Oct; 25(5):522-4. PubMed ID: 9783591
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy for gynecologic tumors].
Machover D
Contracept Fertil Sex; 1996 Apr; 24(4):264-7. PubMed ID: 8704799
[No Abstract] [Full Text] [Related]
11. Gemcitabine plus cisplatin combination given with amifostine (GAP) to heavily pretreated patients with gynecologic and peritoneal cancers: tolerance and activity in ovarian cancer.
Safra T; Jeffers S; Sorich J; Muggia FM
Anticancer Drugs; 1998 Jul; 9(6):511-4. PubMed ID: 9877238
[TBL] [Abstract][Full Text] [Related]
12. A phase II evaluation of tirapazamine plus cisplatin in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group study.
Covens A; Blessing J; Bender D; Mannel R; Morgan M;
Gynecol Oncol; 2006 Mar; 100(3):586-90. PubMed ID: 16249022
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
